Geode Capital Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Geode Capital Management’s Portfolio RETA Stock Details RETA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-593,430	Closed	-$60.5M	–	4814
2023 Q2	$60.5M	Buy	593,430 +44,117	+8%	+$4.5M	0.01%	1110
2023 Q1	$49.9M	Buy	549,313 +23,197	+4%	+$2.11M	0.01%	1187
2022 Q4	$20M	Buy	526,116 +22,196	+4%	+$843K	﹤0.01%	1775
2022 Q3	$12.7M	Buy	503,920 +12,055	+2%	+$303K	﹤0.01%	2070
2022 Q2	$14.9M	Buy	491,865 +40,943	+9%	+$1.24M	﹤0.01%	1972
2022 Q1	$14.8M	Sell	450,922 -11,659	-3%	-$382K	﹤0.01%	2086
2021 Q4	$12.2M	Sell	462,581 -15,251	-3%	-$402K	﹤0.01%	2315
2021 Q3	$48.1M	Buy	477,832 +1,389	+0.3%	+$140K	0.01%	1313
2021 Q2	$67.4M	Buy	476,443 +140,402	+42%	+$19.9M	0.01%	1058
2021 Q1	$33.5M	Buy	336,041 +20,319	+6%	+$2.03M	0.01%	1523
2020 Q4	$39M	Buy	315,722 +34,400	+12%	+$4.25M	0.01%	1285
2020 Q3	$27.4M	Sell	281,322 -26,985	-9%	-$2.63M	0.01%	1293
2020 Q2	$48.1M	Sell	308,307 -58,377	-16%	-$9.11M	0.01%	915
2020 Q1	$52.9M	Buy	366,684 +27,562	+8%	+$3.98M	0.01%	747
2019 Q4	$69.3M	Buy	339,122 +45,169	+15%	+$9.23M	0.01%	762
2019 Q3	$23.6M	Buy	293,953 +52,904	+22%	+$4.25M	0.01%	1370
2019 Q2	$22.7M	Buy	241,049 +25,043	+12%	+$2.36M	0.01%	1402
2019 Q1	$18.5M	Buy	216,006 +23,700	+12%	+$2.03M	﹤0.01%	1463
2018 Q4	$10.8M	Buy	192,306 +10,958	+6%	+$615K	﹤0.01%	1738
2018 Q3	$14.8M	Buy	181,348 +39,926	+28%	+$3.26M	﹤0.01%	1631
2018 Q2	$4.95M	Buy	141,422 +27,191	+24%	+$951K	﹤0.01%	2332
2018 Q1	$2.34M	Buy	114,231 +83	+0.1%	+$1.7K	﹤0.01%	2675
2017 Q4	$3.23M	Buy	114,148 +18,142	+19%	+$514K	﹤0.01%	2476
2017 Q3	$2.99M	Buy	96,006 +27,686	+41%	+$861K	﹤0.01%	2512
2017 Q2	$2.16M	Buy	68,320 +4,542	+7%	+$144K	﹤0.01%	2689
2017 Q1	$1.44M	Buy	63,778 +10,397	+19%	+$235K	﹤0.01%	2833
2016 Q4	$1.17M	Buy	53,381 +758	+1%	+$16.5K	﹤0.01%	2916
2016 Q3	$1.39M	Buy	+52,623	New	+$1.39M	﹤0.01%	2765